Kyverna Therapeutics Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$8.67

+0.05 (+0.58%)

As of Jun 25, 2:41 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target -5.9% upside

Low Target $5.68

Average Target $8.16

High Target $10.96

Current Price $8.67

Current
$8.67

Target
$8.16

$5.68 $8.16 avg $10.96

Scenario Analysis

Bear Case

$5.68

-34.5%

Low target

Base Case

$8.16

-5.9%

Avg target

Bull Case

$10.96

+26.4%

High target

Risk/Reward

0.8x

Unfavorable

Price in Context

52-Week High

$13.67

-36.6% from high

52-Week Low

$2.52

+244.0% from low

Target vs 52W High

$8.16

-40.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+5.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-46.4%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+191.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-9.5%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-36.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-45.5%